Lv1
34 积分 2023-08-22 加入
In situ engineering of mRNA-CAR T cells using spleen-targeted ionizable lipid nanoparticles to eliminate cancer cells
1天前
已完结
Preparation of targeted lipid nanoparticles for precision nucleic acid delivery
9天前
已完结
Overcoming T cell tolerance to tumor self-antigens through catch-bond engineering
1个月前
已完结
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results
1个月前
已完结
Oncolytic virus VG161 in refractory hepatocellular carcinoma
2个月前
已完结
Pancreatic cancer–restricted cryptic antigens are targets for T cell recognition
2个月前
已完结
Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery
3个月前
已完结
Humanized mouse models for immuno-oncology research
4个月前
已完结
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
4个月前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
5个月前
已完结
皖公网安备34019202002308
